Quick answers
- What is Xeomin?
- Xeomin is a brand name of Incobotulinumtoxina, a prescription medicine. The FDA NDC Directory lists 8 Xeomin products in 3 strengths and forms.
- Who makes Xeomin?
- Merz Pharms holds the FDA application for Xeomin (BLA125360, approved July 30, 2010). 1 other company (repackagers or distributors) also list Xeomin products.
- Is there a generic or store brand of Xeomin?
- Yes. The FDA NDC Directory lists 5 other products with the same active ingredients, strength and form as a Xeomin product. Ask your pharmacist whether one is right for you.
- Has Xeomin been recalled?
- No recall linked to Xeomin products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Xeomin is
Each Xeomin product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Incobotulinumtoxina · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| botulinum toxin type a 100 USP units injection, powder, lyophilized, for solution (intramuscular) | Xeomin | 3 products, 2 companies | DailyMed |
| botulinum toxin type a 200 USP units injection, powder, lyophilized, for solution (intramuscular) | Xeomin | 1 product, 1 company | DailyMed |
| botulinum toxin type a 50 USP units injection, powder, lyophilized, for solution (intramuscular) | Xeomin | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Incobotulinumtoxina →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA125360 | Merz Pharms | July 30, 2010 | 8 |
Companies that list Xeomin
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Xeomin products.
- Merz Pharmaceuticals, LLC5 products
- Merz North America, Inc.3 products
Recalls
No recall linked to Xeomin products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.